Forest Pays Up To $10M In MDL Over Celexa, Lexapro

Law360, San Francisco (March 14, 2014, 6:33 PM EDT) -- Forest Laboratories Inc. agreed to pay between $7.7 million and $10.4 million to settle multidistrict litigation accusing the drugmaker of misleading Missouri parents into buying Celexa and Lexapro for children although the drugs were only approved for adults, according to papers filed in Massachusetts federal court Thursday.

The plaintiffs urged U.S. District Court Judge Nathaniel M. Gorton to certify a settling class of parents in Missouri and appoint Pendley Baudin & Coffin LLP and Baum Hedlund Aristei & Goldman PC as the settlement counsel. They also asked the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.